About ALDR

Alder BioPharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that discovers, develops and seeks to commercialize therapeutic antibodies with the potential to meaningfully transform current treatment paradigms. Alder’s lead clinical candidate, ALD403, inhibits a well validated molecule shown to trigger migraine attacks, calcitonin gene-related peptide (CGRP), and is currently undergoing Phase 2b clinical testing for the treatment of chronic migraines. Alder has initiated a pivotal clinical trial for the treatment of frequent episodic migraine and plans to initiate additional advanced clinical trials for ALD403 in frequent episodic and chronic migraine in 2016. Alder’s second program, ALD1613, which targets adrenocorticotropic hormone (ACTH) is undergoing Investigational New Drug (IND)-enabling preclinical studies with the initiation of clinical trials in Congenital Adrenal Hyperplasia or Cushing’s disease planned for 2016. Finally, clazakizumab, previously known as ALD518, is designed to block the pro-inflammatory cytokine IL-6 and has completed a Phase 2b clinical trial. Alder is seeking a partner or other strategic alternatives for clazakizumab.
Primary Exchange: NASDAQ
SIC Pharmaceutical Preparations
NAICS Pharmaceutical Preparation Manufacturing

ALDR is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
BIB ProShares Ultra Nasdaq Biotechnology 247.9 M 2.47865E+08 234 234 0.07% 0.000687401 349 K 348821
UBIO Proshares UltraPro Nasdaq Biotechnology 31.1 M 3.10775E+07 228 228 0.04% 0.000399483 39 K 39124
URTY ProShares UltraPro Russell2000 105.8 M 1.05784E+08 2,016 2016 0.01% 0.000110699 37 K 36777
UWM ProShares Ultra Russell2000 184.1 M 1.84148E+08 2,016 2016 0.01% 0.000147974 60 K 59859
PRFZ Invesco FTSE RAFI US 1500 Small-Mid ETF 2.1 B 2.1424E+09 1,499 1499 0.01% 0.00013 279 K 279255
IBB iShares Nasdaq Biotechnology Index Fund 8.2 B 8.24908E+09 222 222 0.14% 0.0014 11.5 M 1.15036E+07
ITOT iShares Core S&P Total U.S. Stock Market ETF 18.7 B 1.87292E+10 3,568 3568 0.0% 0 558 K 557796
IWM iShares Russell 2000 ETF 44.9 B 4.48577E+10 2,006 2006 0.04% 0.0004 17.3 M 1.72543E+07
IWN iShares Russell 2000 Value ETF 9.2 B 9.22952E+09 1,371 1371 0.02% 0.0002 1.4 M 1393000
IWO iShares Russell 2000 Growth ETF 9.3 B 9.28872E+09 1,239 1239 0.06% 0.0006 5.5 M 5481180
IWV iShares Russell 3000 ETF 9.7 B 9.71954E+09 2,931 2931 0.0% 0 295 K 295043
LABU Direxion Daily S&P Biotech Bull 3X Shares 676.5 M 6.76479E+08 129 129 0.07% 0.000655847 1.6 M 1603050
FHLC Fidelity MSCI Health Care Index ETF 1.6 B 1.6E+09 354 354 0.02% 0.0002002 321 K 320577
ONEQ Fidelity Nasdaq Composite Index Tracking Stock 2.0 B 2E+09 1,005 1005 0.01% 0.000111917 221 K 220690

Wait, Before You Leave...